London Company of Virginia’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-558,734
| Closed | -$69.4M | – | 140 |
|
|
2018
Q2 | $69.4M | Sell |
558,734
-33,099
| -6% | -$4.11M | 0.57% | 51 |
|
|
2018
Q1 | $66M | Buy |
591,833
+5,630
| +1% | +$628K | 0.53% | 56 |
|
|
2017
Q4 | $70.1M | Sell |
586,203
-17,077
| -3% | -$2.04M | 0.51% | 57 |
|
|
2017
Q3 | $84.6M | Sell |
603,280
-17,554
| -3% | -$2.46M | 0.61% | 51 |
|
|
2017
Q2 | $75.5M | Buy |
+620,834
| New | +$75.5M | 0.51% | 64 |
|